Spero Therapeutics
SPRO
SPRO
48 hedge funds and large institutions have $18M invested in Spero Therapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $23.7M → $18M (-$5.63M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
48
Holding in Top 10
–
Calls
$14K
Puts
$1K
Top Buyers
| 1 | +$406K | |
| 2 | +$402K | |
| 3 | +$158K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$88K |
Top Sellers
| 1 | -$367K | |
| 2 | -$183K | |
| 3 | -$140K | |
| 4 |
Squarepoint
New York
|
-$137K |
| 5 |
B
Bailard
Foster City,
California
|
-$105K |